Susceptibilities of Eikenella corrodens, Prevotella intermedia, and Prevotella nigrescens clinical isolates to amoxicillin and tetracycline

被引：10
|
作者：
Luong, N [1 ]
Tsai, J [1 ]
Chen, C [1 ]
机构：
[1] Univ So Calif, Sch Dent, Div Primary Oral Hlth Care, Los Angeles, CA 90089 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 11期
关键词：
D O I：
10.1128/AAC.45.11.3253-3255.2001
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The AB Biodisk Etest showed that 106 (100%) and 98 (92%) isolates of Eikenella corrodens were susceptible to amoxicillin and tetracycline, respectively. Twenty-three (68%) Prevotella intermedia isolates and 14 (67%) Prevotella nigrescens isolates were susceptible to amoxicillin. Seventy-nine percent of the P. intermedia isolates and 67% of the P. nigrescens isolates were susceptible to tetracycline. A higher percentage of beta -lactamase-producing isolates of P. intermedia and P. nigrescens were identified with selective agar containing amoxicillin than with nonselective agar.
引用
收藏
页码：3253 / 3255
页数：3
相关论文
共 50 条
  • [1] Antibiotic Susceptibility and Resistance Genes in Oral Clinical Isolates of Prevotella intermedia, Prevotella nigrescens, and Prevotella melaninogenica
    Castillo, Yormaris
    Andrea Delgadillo, Nathaly
    Neuta, Yineth
    Hernandez, Andres
    Acevedo, Tania
    Cardenas, Edwin
    Montano, Andrea
    Ines Lafaurie, Gloria
    Marcela Castillo, Diana
    ANTIBIOTICS-BASEL, 2022, 11 (07):
  • [2] β-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents
    Mättö, J
    Asikainen, S
    Väisänen, ML
    von Troil-Lindén, B
    Könönen, E
    Saarela, M
    Salminen, K
    Finegold, SM
    Jousimies-Somer, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) : 2383 - 2388
  • [3] Phospholipids of Prevotella intermedia and Prevotella nigrescens.
    Drucker, D
    Maddocks, L
    Boote, V
    Blinkhorn, A
    Tavana, A
    Davies, R
    JOURNAL OF DENTAL RESEARCH, 1996, 75 (05) : 1143 - 1143
  • [4] Glucose metabolism by Prevotella intermedia and Prevotella nigrescens
    Takahashi, N
    Yamada, T
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2000, 15 (03): : 188 - 195
  • [5] Pathogenicity of Prevotella intermedia and Prevotella nigrescens isolates in a wound chamber model in rabbits
    Hafstrom, C
    Dahlen, G
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 1997, 12 (03): : 148 - 154
  • [6] Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain
    Andrés, MT
    Chung, WO
    Roberts, MC
    Fierro, JF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 3022 - 3023
  • [7] Hemolytic and hemagglutinating activities of Prevotella intermedia and Prevotella nigrescens
    Okamoto, M
    Maeda, N
    Kondo, K
    Leung, KP
    FEMS MICROBIOLOGY LETTERS, 1999, 178 (02) : 299 - 304
  • [8] Optimized oligonucleotides for the differentiation of Prevotella intermedia and Prevotella nigrescens
    Conrads, G
    Pelz, K
    Hughes, B
    Seyfarth, I
    Devine, DA
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 1997, 12 (02): : 117 - 120
  • [9] Direct quantitative differentiation between Prevotella intermedia and Prevotella nigrescens in clinical specimens
    Gmür, R
    Thurnheer, T
    MICROBIOLOGY-SGM, 2002, 148 : 1379 - 1387
  • [10] Depolymerising and hydrolytic enzymes of Prevotella intermedia and Prevotella nigrescens.
    Stubbs, S
    Waddington, RJ
    Lewis, M
    Embery, G
    JOURNAL OF DENTAL RESEARCH, 1996, 75 (05) : 1144 - 1144
12345